1-3 of 3
Agnes Benedict
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Economic Evaluation of Carfilzomib+Dexamethasone (Kd) Vs Bortezomib+Dexamethasone (Vd) in Relapsed or Refractory Multiple Myeloma (R/RMM)

Andrzej Jakubowiak, MD PhD, Istvan Matyas Majer, PhD, Ivan Houisse, MSc, Agnes Benedict, Marco Campioni, Sumeet Panjabi, Sikander Ailawadhi, MD
Journal: Blood
Blood (2016) 128 (22): 3582.
https://doi.org/10.1182/blood.V128.22.3582.3582
Published: 2016
Journal Articles

Indirect Comparisons to Assess the Relative Efficacy of Carfilzomib + Lenalidomide + Dexamethasone Versus Panobinostat + Bortezomib + Dexamethasone and Bortezomib + Dexamethasone: A Matching Adjusted Indirect Comparison

Michael Rael, PhD, Agnes Benedict, Jack Ishak, Sarah Cadarette, Marco Campioni, Sumeet Panjabi
Journal: Blood
Blood (2015) 126 (23): 5622.
https://doi.org/10.1182/blood.V126.23.5622.5622
Published: 2015
Journal Articles

Indirect Comparison to Assess the Relative Efficacy of Carfilzomib + Lenalidomide + Dexamethasone Versus Bortezomib + Thalidomide + Dexamethasone: A Matching Adjusted Indirect Comparison

Michael Rael, PhD, Agnes Benedict, Jack Ishak, Sarah Cadarette, Marco Campioni, Sumeet Panjabi
Journal: Blood
Blood (2015) 126 (23): 5624.
https://doi.org/10.1182/blood.V126.23.5624.5624
Published: 2015